期刊文献+

应用蒽环类药物化疗患者血清瘦素、N-端脑钠肽前体与超声心动图的变化

Aleterations of serum leptin,N-terminal pro-brain natriuretic peptide and echocardiography in patients with anthracycline chemotherapy
下载PDF
导出
摘要 目的探讨应用蒽环类药物化疗患者血清瘦素、N-端脑钠肽前体(NT-proBNP)变化及二者与超声心动图之间的关系。方法选取我院住院的女性乳腺癌术后应用蒽环类药物化疗的患者50例,在化疗前、第1疗程结束、第2疗程结束及第4疗程结束监测患者血清瘦素水平及NT-proBNP变化,超声心动图监测左心室射血分数(LVEF)的变化。应用Pearson相关系数分析血清瘦素、NT-proBNP与超声心动图之间的相关性。结果应用蒽环类药物患者化疗前后的血清瘦素及NT-proBNP比较差异均有统计学意义(P<0.01),LVEF化疗前后比较差异有统计学意义(P<0.05);相关性分析显示血清瘦素及NT-proBNP与LVEF呈负相关(分别为r=-0.285、-0.342,均P<0.05)。结论应用蒽环类药物化疗患者随化疗周期的延长血清瘦素水平及NT-proBNP逐渐升高。血清瘦素水平及NT-proBNP与超声心动图中LVEF显著相关,在诊断蒽环类药物致心脏毒性的检测中具有重要的临床意义。 Objective To determine the levels of serum leptin and N-terminal pro-brain natriuretic peptide(NT-proBNP)in patients with anthracycline chemotherapy,and to investigate their relationship with echocardiography. Methods Fifty female breast cancer patients who stayed in the hospital and got postoperative anthracycline chemotherapy were included in this study.The levels of serum leptin,NT-proBNP in the patients were detected,and the left ventricular ejection fraction(LVEF)was evaluated before chemotherapy,at the first course of treatment,at the second course of treatment,and at the fourth course of treatment.The correlations between serum leptin,NT-proBNP and echocardiography were analyzed with Pearson correlation coefficient.Results After the chemotherapy,the levels of serum leptin and NT-proBNP were significantly changed(P 〈0.01),so was the LVEF(P 〈0.05).And there were negative correlations between serum leptin,NT-proBNP and LVEF (r=-0.285,-0.342,bothP〈0.05).Conclusion The levels of serum leptin,NT-proBNP in patients with anthracycline-based chemotherapy were increased as the treatment prolonged.The correlations between serum leptin,NT-proBNP and LVEF may paly a vital role in the diagnosis of anthracycline-induced cardiotoxicity.
出处 《临床荟萃》 CAS 2014年第6期689-691,共3页 Clinical Focus
基金 河北省卫生厅医学科学研究重点课题(20120357)
关键词 乳腺肿瘤 瘦素 利钠肽 超声心动描记术 breast neoplasms leptin Natriuretic peptide,brain anthracycline chemotherapy echocardiography
  • 相关文献

参考文献11

  • 1Feng H,Zheng L,Feng Z,et al.The role of leptin in obesityand the potential for leptin replacement therapy[J].Endocrine,2013,44(1):33-39.
  • 2张宁,郑丽华,冯和林.瘦素与高血压和心力衰竭的研究进展[J].临床荟萃,2012,27(15):1373-1375. 被引量:4
  • 3Despres JP,Lupien PJ,Moorjani S,et al.Leptenemia is not arisk factor for ischemic heart disease in men.Prospectiveresults from Quebec Cardiovascular study [J].Diabetic Care,1998,21(5):782-786.
  • 4张宁,郑丽华,郑金秀,孔雁.脑钠肽和N-末端脑钠肽与化疗药物致心脏毒性的研究进展[J].临床荟萃,2012,27(20):1839-1840. 被引量:2
  • 5张宁,郑金秀,高社军,孔雁,姚铁柱,孙芳毅,刘宇.NT-proBNP与GPBB对蒽环类药物致心脏毒性的早期监测[J].临床心血管病杂志,2013,29(6):449-451. 被引量:10
  • 6Matsuda K,Teragawa H,Fukuda Y,et al.Leptin causes nitric-oxide independent coronary artery vasodilation in humans[J].Hypertens Res,2003,26(2):147-152.
  • 7Cortes R, PortoJes M,Rosello-Lleti E,et al.Impact ofglomerular filtration rate on urinary BNP and NT-proBNPlevels in heart failure [J].Peptides,2012,33(2):354-358.
  • 8Steiner J,Guglin M.BNP or NTproBNP? A clinician'sperspective [J].Int J Cardiol,2008,129(1):5-14.
  • 9Jensen J,Ma LP,Bjurman C,et al.Prognostic values of NTproBNP/BNP ratio in comparison with NTproBNP or BNP alonein elderly patients with chronic heart failure in a 2-year followup [J].Int J Cardiol,2012,155(1):1-5.
  • 10Radiovanovic M,Vasiljevic Z,Radovanovic N,et al.B-typenatriuretic peptide in outpatients after myocardial infarction:optimized cut-off value for incident heart failure prediction [J].Peptides,2010,31(10):1946-1948.

二级参考文献35

  • 1张洁.QT离散度[J].国外医学(心血管疾病分册),1997,24(1):3-6. 被引量:68
  • 2Lee HS, Son CB, Shin SH, et al. Clinical correlation between brain natriutetic peptide and anthracyclin-induced cardiac toxicity[J]. Cancer Res Treat, 2008,40(3) : 121-126.
  • 3Outomuro D, Grana DR, Azzato F. et al. Adriamycin-induced myocardial toxicity: new solutions for an old problem? [J]. Int J Cardiol,2007,117(1) :6-15.
  • 4Wong GC, Ayas NT. Clinical approaches to the diagnosis of acute heart failure[J]. Curr Opin Cardiol, 2007,22 ( 3 ) : 207- 213.
  • 5Daniels LB, Maisel AS. Natriuretic peptides [J ]. J Am Coll Cardiol,2007,50 (25) : 2357-2368.
  • 6Levin ER,Gardner DG. Samson WK. Natriuretic peptides[J]. N Engl J Med,1998,339(5) :321-328.
  • 7Pored JM. Utilization of B-type natriuretic peplide and NT- proBNP in the diagnosis of pleural effusions due to heart failure[J]. Curr Opin Pulm Med,2011,17(4) :215-219.
  • 8Cortes R, Otern MR, Morillas P, et al. Obese and nonobese patients with essential hypertension show similar N-terminal proBNP plasma levels[J]. Am J Hypertens. 2008.21 (7) : 820- 825.
  • 9Welisch E, Norozi K. Rauch R. N-terminal pro brain natriuretic peptide level as a screening tool for cardiac involvement in paediatric diseases of extracardiac origin[J]. Clin Res Cardiol. 2011,100(9) : 723-730.
  • 10Norozi K, Binder L. Brack C, et al. Intravenous luteinizing hormone-releasing hormone has no effect on serum N-terminal pro-brain natriuretic peptide in children and adolescents[J]. Pediatr Int,2009,51(2) :283-288.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部